Receptor-specific targeting mediated by the coexpression of a targeted murine leukemia virus envelope protein and a binding-defective influenza hemagglutinin protein

Human Gene Therapy

Volumn 12, Issue 4, 2001, Pages 323-332

  Lin, A H ^a   Kasahara, N ^b   Wu, W ^b   Stripecke, R ^b   Empig, C L ^c   Anderson, W F ^a,b   Cannon, P M ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CELL SURFACE RECEPTOR; FLT3 LIGAND; HYBRID PROTEIN; LIGAND; VIRUS ENVELOPE PROTEIN; VIRUS HEMAGGLUTININ; VIRUS VECTOR;

ARTICLE; CELL MEMBRANE; GENE TARGETING; HUMAN; HUMAN CELL; MEMBRANE FUSION; MURINE LEUKEMIA VIRUS; RECEPTOR BINDING; RETROVIRUS; VIRUS CELL INTERACTION; VIRUS ENVELOPE;

3T3 CELLS; ANIMALS; BINDING SITES; CELL LINE; FMS-LIKE TYROSINE KINASE 3; GENE PRODUCTS, ENV; GENE TARGETING; GENETIC VECTORS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; LEUKEMIA VIRUS, MURINE; MEMBRANE FUSION; MICE; MUTATION; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, VIRUS; RECOMBINANT FUSION PROTEINS; RETROVIRIDAE; VIRAL ENVELOPE PROTEINS;

ANIMALIA; DNA VIRUSES; MURINAE; MURINE LEUKEMIA VIRUS; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0035119465     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340150503957     Document Type: Article

References (28)

1. Human gene therapy
2. Targeting retroviral vectors to CD34-expressing cells: Binding to CD34 does not catalyze virus-cell fusion
3. Retroviral vectors for human gene therapy
4. Targeting retrovirus entry
5. Retroviral retargeting by envelopes expressing an N-terminal binding domain
6. Strategies to accomplish gene delivery via the receptor-mediated endocytosis pathway
7. Role of variable regions A and B in receptor binding domain of amphotropic murine leukemia virus envelope protein
8. Incorporation of fowl plague virus hemagglutinin into murine leukemia virus particles and analysis of the infectivity of the pseudotyped retroviruses
9. Incorporation of fowl plague virus hemagglutinin into murine leukemia virus particles and analysis of the infectivity of the pseudotyped retroviruses
10. Incorporation of simian virus 5 fusion protein into murine leukemia virus particles and its effect on the coincorporation of retroviral envelope glycoproteins
11. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions
12. Paramyxovirus fusion: A hypothesis for changes
13. Biology of flt3 ligand and receptor
14. Identification of soluble and membrane-bound isoforms of the murine flt3 generated by alternative splicing of mRNAs
15. Identification of a subdomain in the Moloney murine leukemia envelope protein involved in receptor binding
16. Targeted infection of human cells via major histocompatibility complex class I molecules by Moloney murine leukemia virus-derived viruses displaying single-chain antibody fragment-envelope fusion proteins
17. Retroviral vector targeting to melanoma cells by single-chain antibody incorporation in envelope
18. Regulatory roles of the ligand for Flk2/Flt3 tyrosine kinase receptor on human hematopoiesis
19. Antigen-specific membrane fusion mediated by the haemagglutin protein of influenza A virus: Separation of attachment and fusion functions on different molecules
20. Retroviral targeted delivery
21. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles
22. A transient three-plasmid expression system for the production of high titer retroviral vectors
23. Flt3 receptor expression on the surface of normal and malignant human hematopoietic cells
24. Hemagglutinin activation of pathogenic avian influenza viruses of serotype H7 requires the protease recognition motif R-X-K/R-R
25. Retroviral vector targeting human cells via c-Kit-stem cell factor interaction
26. Functional interactions between monomers of the retroviral envelope protein complex
27. Identification of the block in targeted retroviral-mediated gene transfer